- Directors and Auditors
- Articles of Association
- General Meetings
- - Previous General Meetings
- Insider Trading
Dignitana launches DigniCap Mobile App to support patient-centered care
Dignitana Release - wkr0006.pdf
Dignitana AB, world leader in scalp cooling innovation to minimize hair loss from chemotherapy, today announced the relaunch of its new DigniCap® Mobile App, now available as a free download through Google Play (Android) and the Apple App Store (Apple OS).
The DigniCap App reflects Dignitana’s commitment to exemplary customer service and provides the foundation for a new mobile-friendly patient portal that puts mobile payment, patient support, hair care recommendations and frequently asked questions in one convenient place.
“Personalized patient support is a critical component of the service we provide for The DigniCap Scalp Cooling System,” says William Cronin, CEO of Dignitana AB. “Patients are juggling the burden of a cancer diagnosis with all of the other aspects of their busy lives. The DigniCap Mobile App now makes it easy for patients to access our clinical and practical expertise and pay for their scalp cooling treatments with a few clicks.”
Through the App patients can also provide feedback, share progress photos and personal stories, and connect with other members of the DigniCap community through social media.
The DigniCap App is directed to consumers in the United States using products and services of Dignitana, Inc. With the launch of the next generation DigniCap Delta in 2019, Dignitana introduced a new business model and U.S. patients now create an account to order a personal Delta Kit. The DeltaKit contains supplies needed for scalp cooling and patients are then able to go online to purchase DeltaCards for each treatment.
For More Information Contact
Investor Relations +1 469 518 5031 email@example.com
Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001. Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States. Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.com. Eric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 firstname.lastname@example.org www.penser.se
Dignitana enters Hong Kong market with leading distributor Science International Corporation
Dignitana newsletter highlights growth, media coverage and exemplary customer satisfaction
Innovative treatment for hair loss from chemotherapy to be presented at Stora Aktiedagen
Dignitana hires Johan Johansson to Head Operations, Research and Development
Aktiespararna women’s event to feature Dignitana CEO Catarina Mård Löwenadler
Dignitana newsletter highlights growth and customer satisfaction